Clinical Trial Update: Sanaria™ PfSPZ Challenge Vaccine [Phase 1]

View source ↗

Summary

Phase 1 trial update for the Sanaria PfSPZ Challenge Vaccine targeting malaria; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• PfSPZ Challenge Vaccine (PfSPZ Challenge)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Malaria | Phase 1 | Status: COMPLETED